Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Nutrients|September 2, 2020
The Effect of Dietary Supplementation on Aggressive Behaviour in Australian Adult Male Prisoners: A Feasibility and Pilot Study for a Randomised, Double Blind Placebo Controlled TrialColin H Cortie, Mitchell K Byrne, Carole Collier, et al.
Emerging Infectious Diseases|July 24, 2025
Surveillance of Viral Respiratory Infections within Maximum-Security Prison, AustraliaNicolas M Legrand, Rowena A Bull, Behzad Hajarizadeh, et al.
Nature Communications|February 8, 2024
Contribution of climate change to the spatial expansion of West Nile virus in EuropeDiana Erazo, Luke Grant, Guillaume Ghisbain, et al.
Open Forum Infectious Diseases|February 12, 2024
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus EliminationSophy T F Shih, Jack Stone, Natasha K Martin, et al.
Gastro Hep Advances|February 13, 2025
Multiomic Sequencing Reveals Distinctive Gene Expression and Epigenetic Alterations Associated With Primary Sclerosing Cholangitis Development in Treatment-Naïve Pediatric Ulcerative ColitisAlejandra Rodriguez-Sosa, Ololade Lawal, Ciaran McDonnell, et al.
Trials|May 3, 2021
The effect of omega-3 long chain polyunsaturated fatty acids on aggressive behaviour in adult male prisoners: a structured study protocol for a multi-centre, double-blind, randomised placebo-controlled trial and translation into policy and practiceBarbara J Meyer, Mitchell K Byrne, Colin H Cortie, et al.
Drug and Alcohol Review|June 21, 2026
Health, Social and Recidivism Outcomes Among People Who Have Been Incarcerated in New South Wales, Australia: Study Protocol and Cohort Profile for the Prison Outcomes STudy (POST)Louisa Degenhardt, Michael Farrell, Michael Doyle, et al.
The Lancet. Gastroenterology & Hepatology|May 9, 2021
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort studyBehzad Hajarizadeh, Jason Grebely, Marianne Byrne, et al.
BMJ Open|September 3, 2021
Sertraline hydrochloride for reducing impulsive behaviour in male, repeat-violent offenders (ReINVEST): protocol for a phase IV, double-blind, placebo-controlled, randomised clinical trialTony Butler, Peter W Schofield, Lee Knight, et al.
Eclinicalmedicine|December 16, 2025
Sertraline to reduce recidivism in impulsive violent offenders (ReINVEST): a randomised double blind clinical trialTony Butler, Emaediong I Akpanekpo, Lee Knight, et al.
Pageof 5